WE
Wealth Effects Portfolio holdings
AUM
$267M
This Quarter Return
-19.17%
1 Year Return
+17.32%
3 Year Return
+150.6%
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
(-22%)
Cap. Flow
+$7.63M
Cap. Flow
% of AUM
4.59%
Top 10 Holdings %
Top 10 Hldgs %
35.36%
Holding
217
New
13
Increased
90
Reduced
56
Closed
28
Top Buys
| 1 |
Amazon
AMZN
|
$6.13M |
| 2 |
indie Semiconductor
INDI
|
$1.17M |
| 3 |
Organon & Co
OGN
|
$1.05M |
| 4 |
Apple
AAPL
|
$871K |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$505K |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$1.22M |
| 2 |
Adobe
ADBE
|
$507K |
| 3 |
Citigroup
C
|
$447K |
| 4 |
Meta Platforms (Facebook)
META
|
$436K |
| 5 |
XYZ
Block, Inc.
XYZ
|
$408K |
Sector Composition
| 1 | Technology | 24.35% |
| 2 | Healthcare | 23.71% |
| 3 | Financials | 9.68% |
| 4 | Communication Services | 8.4% |
| 5 | Consumer Discretionary | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $15.6M | 9.4% | 114,211 +6,368 | +6% | +$871K |
|
|
2
Amazon
AMZN
$2.44T
| $6.45M | 3.88% | 60,681 +57,750 | +1,970% | +$6.13M |
|
|
AVDL
3
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.31M | 3.79% | 2,584,090 +206,800 | +9% | +$505K |
|
4
Microsoft
MSFT
$3.77T
| $5.53M | 3.33% | 21,521 +1,104 | +5% | +$284K |
|
5
Arrowhead Research
ARWR
$3.05B
| $5.41M | 3.26% | 153,620 +3,400 | +2% | +$120K |
|
6
NVIDIA
NVDA
$4.24T
| $4.19M | 2.52% | 27,631 -405 | -1% | -$61.4K |
|
7
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$5.3B
| $3.91M | 2.35% | 80,881 +756 | +0.9% | +$36.5K |
|
8
Alphabet (Google) Class A
GOOGL
$2.57T
| $3.88M | 2.34% | 1,781 -1 | -0.1% | -$2.18K |
|
9
Pfizer
PFE
$141B
| $3.86M | 2.32% | 73,580 +3,198 | +5% | +$168K |
|
10
JPMorgan Chase
JPM
$829B
| $3.62M | 2.18% | 32,143 +396 | +1% | +$44.6K |
|
11
Blackstone
BX
$134B
| $3.34M | 2.01% | 36,617 +508 | +1% | +$46.4K |
|
12
3D Systems Corporation
DDD
$295M
| $2.59M | 1.56% | 266,925 +650 | +0.2% | +$6.31K |
|
13
Chevron
CVX
$324B
| $2.35M | 1.41% | 16,227 +121 | +0.8% | +$17.5K |
|
14
Trade Desk
TTD
$26.7B
| $2.26M | 1.36% | 53,875 -4,950 | -8% | -$207K |
|
15
Beyond Air
XAIR
$11.6M
| $2.19M | 1.32% | 327,909 +33,500 | +11% | +$224K |
|
16
AbbVie
ABBV
$372B
| $2.18M | 1.31% | 14,238 +491 | +4% | +$75.2K |
|
17
Steris
STE
$24.1B
| $2.17M | 1.31% | 10,543 -33 | -0.3% | -$6.8K |
|
18
CVS Health
CVS
$92.8B
| $1.94M | 1.16% | 20,887 +101 | +0.5% | +$9.36K |
|
19
UnitedHealth
UNH
$281B
| $1.86M | 1.12% | 3,627 +255 | +8% | +$131K |
|
20
Johnson & Johnson
JNJ
$427B
| $1.86M | 1.12% | 10,489 +282 | +3% | +$50.1K |
|
21
Roku
ROKU
$14.2B
| $1.85M | 1.11% | 22,494 +2,350 | +12% | +$193K |
|
22
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.15B
| $1.74M | 1.05% | 99,440 +7,960 | +9% | +$139K |
|
23
American Tower
AMT
$95.5B
| $1.58M | 0.95% | 6,192 -75 | -1% | -$19.2K |
|
24
Bank of America
BAC
$376B
| $1.56M | 0.94% | 50,053 -1,163 | -2% | -$36.2K |
|
25
Merck
MRK
$210B
| $1.5M | 0.91% | 16,500 +118 | +0.7% | +$10.8K |
|